Jithendran N, Jerome J Terrence Jose
Trustwell Hospitals, Bangalore, India.
Department of Orthopedics, Hand, and Reconstructive Microsurgery, Olympia Hospital & Research Centre, Tamilnadu, India.
J Hand Surg Glob Online. 2024 May 3;7(2):272-276. doi: 10.1016/j.jhsg.2024.02.018. eCollection 2025 Mar.
This study reviews distal fingertip replants without heparin, aiming to assess their functional outcomes.
This retrospective study reviewed all patients who underwent distal fingertip replants in two specialized hand surgery center over 7 years (2016-2023). Patient demographics, injury mechanism, ischemia time, complications, and functional outcomes were analyzed. The functional outcomes were assessed using the Fingertip Injuries Outcome Score.
A total of 30 patients underwent distal fingertip replantation without heparin during the study period. The mean age was 31 years (range, 8-56 years). Machine cut avulsion (23 cases) was the common injury. The mean ischemia time was 7.4 hours. Twenty-five distal replants survived. Fingertip Injuries Outcome Scores categorized outcomes as excellent (n = 10), good (n = 10), fair (n = 5), and poor (n = 5). Complications included shortening (n = 5), nail dystrophy (n = 1), and cold intolerance (n = 1).
This study suggests favorable functional outcomes for distal fingertip replants without heparin. No significant complications were observed, suggesting that heparin may not be necessary for all cases. Further research is needed for more explicit guidelines on heparin use in fingertip replantation.
TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
本研究回顾了未使用肝素的指尖远端再植手术,旨在评估其功能结局。
这项回顾性研究纳入了在7年期间(2016 - 2023年)于两个专业手外科中心接受指尖远端再植手术的所有患者。分析了患者的人口统计学资料、损伤机制、缺血时间、并发症及功能结局。使用指尖损伤结局评分来评估功能结局。
在研究期间,共有30例患者接受了未使用肝素的指尖远端再植手术。平均年龄为31岁(范围8 - 56岁)。机器切割撕脱伤(23例)是常见损伤类型。平均缺血时间为7.4小时。25例远端再植成功存活。指尖损伤结局评分将结局分为优(n = 10)、良(n = 10)、可(n = 5)和差(n = 5)。并发症包括缩短(n = 5)、指甲营养不良(n = 1)和冷不耐受(n = 1)。
本研究表明,未使用肝素的指尖远端再植手术具有良好的功能结局。未观察到显著并发症,这表明并非所有病例都需要使用肝素。需要进一步研究以制定更明确的指尖再植术中肝素使用指南。
研究类型/证据水平:治疗性IV级。